Novel Therapeutic Approaches to Target Movement Disorders: Discovery to Clinic – Craig Lindsley
2006 Rennebohm Hall 777 Highland Ave., MadisonThis lecture will discuss the basic pharmacology of Parkinson’s disease and dystonia, target identification and validation with novel GPCR ligands. Specifically, Craig Lindsley will discuss the development of mGlu4 PAMs